COVID-19, Post-hospitalization, Disease Impact
Conditions
Brief summary
There are currently no precise data available on the impact of COVID-19 on the daily life of patients after hospitalization. For the moment, studies have only demonstrated a strong impact of the diagnosis on the domains of quality of life explored by the MOS-SF36 questionnaire and the PHQ-9 depression score. Concerning the impact of COVID-19 disease after conventional hospitalization, field reports indicate extremely intense fatigue and a major physical impact lasting several weeks
Interventions
SF-12, GHQ-12 and HAQ
Sponsors
Study design
Eligibility
Inclusion criteria
* Adult patient * Patient with a diagnosis of COVID-19 confirmed by PCR and/or CT scan * Patient hospitalized in a short stay unit (excluding intensive care and rehabilitation) for a COVID-19 infection * Patient providing oral consent to participate in the study * Patient able to understand and answer the questionnaires used * Patient able to answer the questions on an electronic device and to receive requests by email and/or SMS * Patient who has electronic equipment at home and an Internet subscription allowing him/her to answer the questionnaires online
Exclusion criteria
* Patient under guardianship, curatorship or a measure of judicial safeguard
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to PASS and CID in patients discharged from conventional hospitalization for COVID-19 disease | Through study completion, an average of 6 months |
| The value of perceived health scores in patients who achieved PASS and MCII | Through study completion, an average of 6 months |
Countries
France